A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients

• Auteurs principaux: Bertalan Fekete (Auteur), Lili Bársony (Auteur), Krisztina Biró (Auteur), Fruzsina Gyergyay (Auteur), Lajos Géczi (Auteur), Attila Patócs (Auteur), Barna Budai (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2023-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background and Objective: Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) have co-morbidities treated with different drugs. The aim was to quantify the potential effect of co-medications on AA treatment duration (TD) and overall survival (O...